While CELF1 has been best characterized in the context of myotonic dystrophy type 1 (DM1) models (17, 18), a growing body of work has associated CELF1 overexpression with cancer proliferation, migration, invasion, and overall tumor aggressivity in multiple cancer models (19, 20, 21, 22). Here, CELF1 is linked to cancer.